Glaxosmithkline Plc


'Glaxosmithkline Plc' - 28 News Result(s)

  • GlaxoSmithKline In Exclusive Talks To Sell Horlicks Unit To Unilever: Report

    GlaxoSmithKline In Exclusive Talks To Sell Horlicks Unit To Unilever: Report

    Unilever beat a bid from Swiss rival Nestle which was also bidding for the unit and looking to expand its portfolio in the powdered hot beverages category, the report added.

  • Glaxo Seeks Mid-September Bids For $4 Billion Indian Horlicks Unit: Report

    Glaxo Seeks Mid-September Bids For $4 Billion Indian Horlicks Unit: Report

    UK pharmaceutical giant GlaxoSmithKline Plc has requested bids by mid-September for its $4.3 billion Indian consumer-health unit, which owns the popular malted milk brand Horlicks, people with knowledge of the matter said.

  • UK Competition Authorities Fine GlaxoSmithKline $54.5 Million

    UK Competition Authorities Fine GlaxoSmithKline $54.5 Million

    Britain's competition authority has fined drug maker GlaxoSmithKline plc 37.6 million pounds ($54.5 million) for stalling the potential entry of generic competitors of an anti-depressant drug Seroxat into the marketplace.

  • You Probably Have Herpes: WHO

    You Probably Have Herpes: WHO

    Two-thirds of the world's population under 50 have the highly infectious herpes virus that causes cold sores around the mouth, the World Health Organization said on Wednesday, in its first estimate of global prevalence of the disease.

  • Cipla Expects to Double Respiratory Drug Sales by 2020

    Cipla Expects to Double Respiratory Drug Sales by 2020

    Cipla Ltd, India's fourth-largest drug maker by revenue, expects sales from its respiratory drug portfolio to more than double by 2020 and remains on track to launch a keenly awaited inhaler in Britain, its chief executive said.

  • Novartis Okays OTC Unit Sale to GSK Consumer

    Novartis Okays OTC Unit Sale to GSK Consumer

    The move follows a global deal struck in April last year, under which Swiss-based Novartis AG had agreed with UK-based GlaxoSmithKline plc to create a global consumer healthcare joint venture, GlaxoSmithKline Consumer Private Ltd (GSK CPL), as part of its global portfolio transformation.

  • Novartis-GSK Pharma Deal Cleared by CCI

    Novartis-GSK Pharma Deal Cleared by CCI

    The Competition Commission of India (CCI) has approved a multi-billion dollar deal between global pharma giants GlaxoSmithKline Plc and Novartis, as it does not find the transaction to be anti-competitive in India.

  • China Hands GlaxoSmithKline Record $489 Million Fine

    China Hands GlaxoSmithKline Record $489 Million Fine

    China fined GlaxoSmithKline Plc a record 3 billion yuan ($490 million) on Friday for paying bribes to doctors to use its drugs, underlining the risks of doing business there while also ending a damaging chapter for the British drug maker.

  • US Emergency Labs Ready to Work on Ebola Drugs if Asked

    US Emergency Labs Ready to Work on Ebola Drugs if Asked

    All three US facilities established to quickly make vaccines and therapeutics in the event of a major public health threat say they are standing by to support any U.S. government effort to scale up a treatment for Ebola.

  • Prices of More Essential Drugs May be Capped: Report

    Prices of More Essential Drugs May be Capped: Report

    The committee will consider adding more drugs to the National List of Essential Medicines (NLEM), all of which would then come under price controls, one of the people told Reuters.

  • Big Pharma Beware, GSK China Case May be Just the Beginning: Report

    Big Pharma Beware, GSK China Case May be Just the Beginning: Report

    The charges relating to GSK executives, accused of funnelling hundreds of millions of dollars in bribes to doctors and health officials via travel agencies, were announced by Chinese authorities last week, the culmination of a 10-month police investigation.

  • Chinese Police Charge Former GSK China Head With Bribery

    Chinese Police Charge Former GSK China Head With Bribery

    Mark Reilly, former head of China operations, and two other executives, Zhang Guowei and Zhao Hongyan, were also suspected of bribing officials in the industry and commerce departments of Beijing and Shanghai, Xinhua said.

  • GSK faces bribery investigation in Poland: report

    GSK faces bribery investigation in Poland: report

    The BBC reported that 11 doctors and a GSK regional manager have been charged over alleged corruption between 2010 and 2012.

  • GlaxoSmithKline to expand product offerings under Horlicks brand

    GlaxoSmithKline to expand product offerings under Horlicks brand

    GlaxoSmithKline Consumer Healthcare (GSKCH) is working towards increasing product offerings under its Horlicks brand and strengthen presence in North and West India to enhance its market position.

  • GSK's open offer to start from February 18

    GSK's open offer to start from February 18

    GlaxoSmithKline Plc's (GSK) share tender offer worth nearly Rs 6,400 crore to raise its stake in the Indian unit will start on February 18th and end of March 5th, the manager to the offer said in a notice to the exchanges on Monday.

'Glaxosmithkline Plc' - 28 News Result(s)

  • GlaxoSmithKline In Exclusive Talks To Sell Horlicks Unit To Unilever: Report

    GlaxoSmithKline In Exclusive Talks To Sell Horlicks Unit To Unilever: Report

    Unilever beat a bid from Swiss rival Nestle which was also bidding for the unit and looking to expand its portfolio in the powdered hot beverages category, the report added.

  • Glaxo Seeks Mid-September Bids For $4 Billion Indian Horlicks Unit: Report

    Glaxo Seeks Mid-September Bids For $4 Billion Indian Horlicks Unit: Report

    UK pharmaceutical giant GlaxoSmithKline Plc has requested bids by mid-September for its $4.3 billion Indian consumer-health unit, which owns the popular malted milk brand Horlicks, people with knowledge of the matter said.

  • UK Competition Authorities Fine GlaxoSmithKline $54.5 Million

    UK Competition Authorities Fine GlaxoSmithKline $54.5 Million

    Britain's competition authority has fined drug maker GlaxoSmithKline plc 37.6 million pounds ($54.5 million) for stalling the potential entry of generic competitors of an anti-depressant drug Seroxat into the marketplace.

  • You Probably Have Herpes: WHO

    You Probably Have Herpes: WHO

    Two-thirds of the world's population under 50 have the highly infectious herpes virus that causes cold sores around the mouth, the World Health Organization said on Wednesday, in its first estimate of global prevalence of the disease.

  • Cipla Expects to Double Respiratory Drug Sales by 2020

    Cipla Expects to Double Respiratory Drug Sales by 2020

    Cipla Ltd, India's fourth-largest drug maker by revenue, expects sales from its respiratory drug portfolio to more than double by 2020 and remains on track to launch a keenly awaited inhaler in Britain, its chief executive said.

  • Novartis Okays OTC Unit Sale to GSK Consumer

    Novartis Okays OTC Unit Sale to GSK Consumer

    The move follows a global deal struck in April last year, under which Swiss-based Novartis AG had agreed with UK-based GlaxoSmithKline plc to create a global consumer healthcare joint venture, GlaxoSmithKline Consumer Private Ltd (GSK CPL), as part of its global portfolio transformation.

  • Novartis-GSK Pharma Deal Cleared by CCI

    Novartis-GSK Pharma Deal Cleared by CCI

    The Competition Commission of India (CCI) has approved a multi-billion dollar deal between global pharma giants GlaxoSmithKline Plc and Novartis, as it does not find the transaction to be anti-competitive in India.

  • China Hands GlaxoSmithKline Record $489 Million Fine

    China Hands GlaxoSmithKline Record $489 Million Fine

    China fined GlaxoSmithKline Plc a record 3 billion yuan ($490 million) on Friday for paying bribes to doctors to use its drugs, underlining the risks of doing business there while also ending a damaging chapter for the British drug maker.

  • US Emergency Labs Ready to Work on Ebola Drugs if Asked

    US Emergency Labs Ready to Work on Ebola Drugs if Asked

    All three US facilities established to quickly make vaccines and therapeutics in the event of a major public health threat say they are standing by to support any U.S. government effort to scale up a treatment for Ebola.

  • Prices of More Essential Drugs May be Capped: Report

    Prices of More Essential Drugs May be Capped: Report

    The committee will consider adding more drugs to the National List of Essential Medicines (NLEM), all of which would then come under price controls, one of the people told Reuters.

  • Big Pharma Beware, GSK China Case May be Just the Beginning: Report

    Big Pharma Beware, GSK China Case May be Just the Beginning: Report

    The charges relating to GSK executives, accused of funnelling hundreds of millions of dollars in bribes to doctors and health officials via travel agencies, were announced by Chinese authorities last week, the culmination of a 10-month police investigation.

  • Chinese Police Charge Former GSK China Head With Bribery

    Chinese Police Charge Former GSK China Head With Bribery

    Mark Reilly, former head of China operations, and two other executives, Zhang Guowei and Zhao Hongyan, were also suspected of bribing officials in the industry and commerce departments of Beijing and Shanghai, Xinhua said.

  • GSK faces bribery investigation in Poland: report

    GSK faces bribery investigation in Poland: report

    The BBC reported that 11 doctors and a GSK regional manager have been charged over alleged corruption between 2010 and 2012.

  • GlaxoSmithKline to expand product offerings under Horlicks brand

    GlaxoSmithKline to expand product offerings under Horlicks brand

    GlaxoSmithKline Consumer Healthcare (GSKCH) is working towards increasing product offerings under its Horlicks brand and strengthen presence in North and West India to enhance its market position.

  • GSK's open offer to start from February 18

    GSK's open offer to start from February 18

    GlaxoSmithKline Plc's (GSK) share tender offer worth nearly Rs 6,400 crore to raise its stake in the Indian unit will start on February 18th and end of March 5th, the manager to the offer said in a notice to the exchanges on Monday.

Your search did not match any documents
A few suggestions
  • Make sure all words are spelled correctly
  • Try different keywords
  • Try more general keywords
Check the NDTV Archives:https://archives.ndtv.com

................................ Advertisement ................................

................................ Advertisement ................................